| Detected | Trial | Change |
|---|---|---|
| 2026-05-14 | NCT07354932 A Study of SHR-2173 in Participants With Primary IgA Nephropathy |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-03 | NCT07622342 A Phase II Study of SHR-2173 Injection in Patients With Myasthenia Gravis | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07289763 | Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety… | Primary Membranous Nephropathy | Recruiting |
| NCT07299422 | A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus | Systemic Lupus Erythematosus | Recruiting |
| NCT07354932 | A Study of SHR-2173 in Participants With Primary IgA Nephropathy | Primary IgA Nephropathy | Recruiting |
| NCT07622342 | A Phase II Study of SHR-2173 Injection in Patients With Myasthenia Gravis | Generalized Myasthenia Gravis | Not Yet Recruiting |
| Phase 1 | |||
| NCT07206758 | Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia | Immune Thrombocytopenia | Recruiting |